| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3856 |
| Trial ID | NCT06373991 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ET-901|ATHENA CAR-T |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase 1 Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Moderate or Severe Systemic Lupus Erythematosus |
| Year | 2024 |
| Country | China |
| Company sponsor | EdiGene Inc. |
| Other ID(s) | EDI-901-SLE01 |
| Cohort 1 | |||||||||
|
|||||||||